相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Enhancing biocompatibility of PCL/PU nano-structures to control the water wettability by NaOH hydrolysis treatment for tissue engineering applications
Nafiseh Jirofti et al.
JOURNAL OF INDUSTRIAL TEXTILES (2022)
Review of advances in electrospinning-based strategies for spinal cord regeneration
Yiran Li et al.
MATERIALS TODAY CHEMISTRY (2022)
Melt electrowriting of PLA, PCL, and composite PLA/PCL scaffolds for tissue engineering application
Mohammad Shahverdi et al.
SCIENTIFIC REPORTS (2022)
Obstacles to Glioblastoma Treatment Two Decades after Temozolomide
Joao Victor Roza Cruz et al.
CANCERS (2022)
Surface Roughness and Biocompatibility of Polycaprolactone Bone Scaffolds: An Energy-Density-Guided Parameter Optimization for Selective Laser Sintering
Jian Han et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Design of Biopolymer-Based Interstitial Therapies for the Treatment of Glioblastoma
Erik S. Pena et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A Smart Hyperthermia Nanofiber-Platform-Enabled Sustained Release of Doxorubicin and 17AAG for Synergistic Cancer Therapy
Lili Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Application of Electrospinning in Antibacterial Field
Honghai Li et al.
NANOMATERIALS (2021)
N6-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 Expression
Giovanna Navarra et al.
FRONTIERS IN ONCOLOGY (2020)
Carmustine as a Supplementary Therapeutic Option for Glioblastoma: A Systematic Review and Meta-Analysis
Zhi-Ze Xiao et al.
FRONTIERS IN NEUROLOGY (2020)
Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancer
Ganji Purnachandra Nagaraju et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Degradation mechanisms of polycaprolactone in the context of chemistry, geometry and environment
Michal Bartnikowski et al.
PROGRESS IN POLYMER SCIENCE (2019)
Hyperthermia Nanofiber Platform Synergized by Sustained Release of Paclitaxel to Improve Antitumor Efficiency
Eri Niiyama et al.
ADVANCED HEALTHCARE MATERIALS (2019)
Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer
Ryan C. Gimple et al.
GENES & DEVELOPMENT (2019)
Recurrent glioblastomas: Should we operate a second and even a third time?
Yahia-Cherif Djamel-Eddine et al.
INTERDISCIPLINARY NEUROSURGERY-ADVANCED TECHNIQUES AND CASE MANAGEMENT (2019)
Polycaprolactone/carboxymethyl chitosan nanofibrous tissue engineering application
Fereshteh Sharifi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2018)
Nano based drug delivery systems: recent developments and future prospects
Jayanta Kumar Patra et al.
JOURNAL OF NANOBIOTECHNOLOGY (2018)
The clinical value of patient-derived glioblastoma tumorspheres in predicting treatment response
Quintino Giorgio D'Alessandris et al.
NEURO-ONCOLOGY (2017)
Small molecule inhibitor screening identifified HSP90 inhibitor 17-AAG as potential therapeutic agent for gallbladder cancer
Helga Weber et al.
ONCOTARGET (2017)
Overcoming blood brain barrier with a dual purpose Temozolomide loaded Lactoferrin nanoparticles for combating glioma (SERP-17-12433)
Sonali Kumari et al.
SCIENTIFIC REPORTS (2017)
Polycaprolactone nanofibrous mesh reduces foreign body reaction and induces adipose flap expansion in tissue engineering chamber
Lin Luo et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Polifeprosan 20, 3.85% carmustine slow release wafer in malignant glioma: patient selection and perspectives on a low-burden therapy
Lawrence Kleinberg
PATIENT PREFERENCE AND ADHERENCE (2016)
A New Epigenetic Mechanism of Temozolomide Action in Glioma Cells
Anna-Maria Barciszewska et al.
PLOS ONE (2015)
Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea
So Hyun Bae et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2014)
Sublethal concentrations of 17-AAG suppress homologous recombination DNA repair and enhance sensitivity to carboplatin and olaparib in HR proficient ovarian cancer cells
Young Eun Choi et al.
ONCOTARGET (2014)
The influence of surgery on recurrence pattern of glioblastoma
Pasquale De Bonis et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2013)
The role of Gliadel wafers in the treatment of high-grade gliomas
Amade Bregy et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2013)
Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results
Takahiro Oike et al.
PLOS ONE (2013)
Temozolomide (Temodar)
J. R. Wesolowski et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2010)
Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining
Brandi L. Mahaney et al.
BIOCHEMICAL JOURNAL (2009)
Enhanced radiosensitization of human glioma cells by combining inhibition of poly(ADP-ribose) polymerase with inhibition of heat shock protein 90
Fiona A. Dungey et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Efficacy of the HSP90 inhibitor 17-AAG in human glioma cell lines and tumorigenic glioma stem cells
Claire Marie-Elisabeth Sauvageot et al.
NEURO-ONCOLOGY (2009)
Down regulation of BRCA2 causes radio-sensitization of human tumor cells in vitro and in vivo
Dong Yu et al.
CANCER SCIENCE (2008)
Preclinical versus clinical drug combination studies
Ting-Chao Chou
LEUKEMIA & LYMPHOMA (2008)
Extracellular heat shock protein 90: A role for a molecular chaperone in cell motility and cancer metastasis
Shinji Tsutsumi et al.
CANCER SCIENCE (2007)
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C
H Pelicano et al.
LEUKEMIA (2006)
Heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin potentiates the radiation response of tumor cells grown as monolayer cultures and spheroids by inducing apoptosis
H Machida et al.
CANCER SCIENCE (2005)
Cerebral edema associated with Gliadel wafers: Two case studies
EL Weber et al.
NEURO-ONCOLOGY (2005)
Composite cell support membranes based on collagen and polycaprolactone for tissue engineering of skin
NT Dai et al.
BIOMATERIALS (2004)
Phase II study of temozolomide in heavily pretreated cancer patients with brain metastases
C Christodoulou et al.
ANNALS OF ONCOLOGY (2001)
分享论文
